PUBLICATIONS · 19224841
Phase II study of weekly gemcitabine and vinorelbine for children with recurrent or refractory Hodgkin's disease: a children's oncology group report.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2009 Mar 20
- First author
- Cole PD
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Cole PD
- type
- Author
- name
- Schwartz CL
- type
- Author
- name
- Drachtman RA
- type
- Author
- name
- de Alarcon PA
- type
- Author
- name
- Chen L
- type
- Author
- name
- Trippett TM
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Cole PD
- type
- Author
- name
- Schwartz CL
- type
- Author
- name
- Drachtman RA
- type
- Author
- name
- de Alarcon PA
- type
- Author
- name
- Chen L
- type
- Author
- name
- Trippett TM
- type
- Author
- bibliography ids
- nci-bib-e62fa2fc5877f8d0e1c45285
- book metadata
- content sha256
- 4a31ee839f9876af40a8d3c08e3b0b7663ce9d28e8c3af495656ef33619c491b
- document type
- citation
- dois
- 10.1200/JCO.2008.20.3778
- electronic publication date
- display
- 2009 Feb 17
- precision
- day
- year
- 2009
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:19224841
- immutable id
- pubmed:19224841@4a31ee839f9876af40a8d3c08e3b0b7663ce9d28e8c3af495656ef33619c491b
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 9
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 1456-61
- volume
- 27
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 19224841
- provenance
- batch id
- 27a383f06e5fc3d04fad
- provider
- NCBI PubMed ESummary
- record sha256
- 34e92e976ec015c5e621fae56b8bbaa30d43dac6d0db6abcdaf537fedec41249
- response sha256
- 51f0f2a142dbd9b135e872b049b116f51941299445a5416feae10f12fac8d978
- retrieved at
- 2026-09-09T23:46:24.265787+00:00
- publication date
- display
- 2009 Mar 20
- precision
- day
- year
- 2009
- publication types
- Clinical Trial, Phase II
- Journal Article
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Phase II study of weekly gemcitabine and vinorelbine for children with recurrent or refractory Hodgkin's disease: a children's oncology group report.
Preserved source evidence · Not medical advice
Triangle